ELGX Share Price

Open 4.73 Change Price %
High 4.79 1 Day 0.00 0.00
Low 4.68 1 Week 0.10 2.16
Close 4.74 1 Month -0.20 -4.05
Volume 688759 1 Year -7.64 -61.71
52 Week High 14.49
52 Week Low 4.20
ELGX Important Levels
Resistance 2 4.84
Resistance 1 4.80
Pivot 4.74
Support 1 4.68
Support 2 4.64
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Endologix, Inc. (NASDAQ: ELGX)

ELGX Technical Analysis 5
As on 23rd Jun 2017 ELGX Share Price closed @ 4.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.42 & Strong Sell for SHORT-TERM with Stoploss of 5.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
ELGX Target for June
1st Target up-side 6.71
2nd Target up-side 8.03
3rd Target up-side 9.35
1st Target down-side 2.93
2nd Target down-side 1.61
3rd Target down-side 0.29
ELGX Other Details
Segment EQ
Market Capital 805434880.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.endologix.com
ELGX Address
ELGX
11 Studebaker
Irvine, CA 92618
United States
Phone: 949-595-7200
ELGX Latest News
Interactive Technical Analysis Chart Endologix, Inc. ( ELGX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Endologix, Inc.
ELGX Business Profile
Endologix, Inc. (Endologix) is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company�s principal product is a stent graft and delivery system (ELG System), for the treatment of abdominal aortic aneurysms (AAA) through endovascular repair (EVAR). Its ELG System consists of a self-expanding cobalt chromium alloy stent covered by expanded polytetrafluoroethylene (ePTFE) graft material (ELG Device) and an accompanying delivery catheter. Once its ELG Device is fixed in its proper position within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. Its ELG System consists of the Company�s ELG Device and catheter delivery system. It also offers proximal aortic extensions and limb extensions, which attach to the main body of its ELG Device.